Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015-Reference-Cited by-同舟云学术

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015

Published:2016-02 Issue:2 Volume:14 Page:153-162
ISSN:1540-1405
Container-title:Journal of the National Comprehensive Cancer Network
language:en
Short-container-title:J Natl Compr Canc Netw

Author:

Daly Mary B.,Pilarski Robert,Axilbund Jennifer E.,Berry Michael,Buys Saundra S.,Crawford Beth,Farmer Meagan,Friedman Susan,Garber Judy E.,Khan Seema,Klein Catherine,Kohlmann Wendy,Kurian Allison,Litton Jennifer K.,Madlensky Lisa,Marcom P. Kelly,Merajver Sofia D.,Offit Kenneth,Pal Tuya,Rana Huma,Reiser Gwen,Robson Mark E.,Shannon Kristen Mahoney,Swisher Elizabeth,Voian Nicoleta C.,Weitzel Jeffrey N.,Whelan Alison,Wick Myra J.,Wiesner Georgia L.,Dwyer Mary,Kumar Rashmi,Darlow Susan

Publisher

Harborside Press, LLC

Subject

Oncology

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of germline genetic testing referral and completion in ovarian cancer patients at a Comprehensive Cancer Center;Gynecologic Oncology;2024-07

2. Fertility Preservation in BRCA1/2 Germline Mutation Carriers: An Overview;Life;2024-05-10

3. Age-specific breast and ovarian cancer risks associated with germline BRCA1 or BRCA2 pathogenic variants – an Asian study of 572 families;The Lancet Regional Health - Western Pacific;2024-03

4. Breast density in NF1 women: a retrospective study;Familial Cancer;2024-01-25

5. Poly(ADP-ribose) polymerase inhibitors in the treatment landscape of triple-negative breast cancer (TNBC);Journal of Oncology Pharmacy Practice;2023-08-09